Medical University of South Carolina Clinical Trials
Sponsors / Medical University of South Carolina
According to ClinicalTrials.gov, Medical University of South Carolina has served as lead sponsor on 749 registered trials. Across the portfolio, 123 are in recruitment, 22 are active non-recruiting, and 512 have reached completion. 57 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Across the portfolio, planned enrollment totals 159,865 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
749
Total Trials
123
Recruiting
22
Other Active
512
Completed
57
Terminated / Withdrawn
159,865
Total Enrollment
Termination reasons: Recruitment46% · Other30% · Funding11% · PI/or_Site5% · Efficacy4% · Safety4% · Regulatory2%
Recent Terminations
- Breast Cancer"Failure to reach study enrollment milestones"
- Intrathecal Morphine"The study was stopped early based on the anecdotal evidence from a surgeon who felt one group was experiencing more side effects than the other. Exposing pediatric patients who would be assigned to the inferior arm was difficult to justify "
- Non-Small Cell Lung Cancer"Study drug was discontinued by manufacturer for business reasons."
- Major Depressive Disorder"Primary Investigator leaving institution"
- Intubation"Study team decided to conclude the study and report it as a feasibility study."
- Head and Neck Cancer"Study was terminated with 50% enrollment by the sponsor due to under enrollment into specific diverse racial, ethnic, and sex/gender categories.~https://grants.nih.gov/policy/inclusion/women-and-minorities.htm"
- Nutritional Deficiency"low enrollment, lack of funding"
- NCT03862066 Stopped Nov 2021Squamous Cell Carcinoma of the Head and Neck"Low accrual progress per internal scientific review committee"
- Stroke"Due to COVID-19 and loss of funding"
- Paresis"Sponsor stoppage of recruitment"
Active Trials (22 total)
- NCT07044466
- NCT05959434
- NCT07076212
- NCT06332209
- NCT04061746
- NCT06205342
- NCT04903028
- NCT05095532
- NCT05901675
- NCT05816083
- NCT07278518
- NCT05486234
- NCT07225010
- NCT05896033
- NCT06118502
- Lymphatic Malformation PHASE2NCT04861064
- NCT05493254
- NCT05764759
- NCT06922617
- Depression NANCT04263285